D-Glucopyranosyl-phenyl-substituted cycles of general formula I ##STR00001## wherein the groups R.sup.1 to R.sup.6, Z, Cy and R.sup.7a, R.sup.7b, R.sup.7c, R.sup.7d are defined as in claim 1, have an inhibiting effect on the sodium-dependent glucose cotransporter SGLT. The present invention also relates to pharmaceutical compositions for the treatment of metabolic disorders.

 
Web www.patentalert.com

< Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions

> Pharmaceutically active uridine esters

~ 00457